Covid-19 Impact on Tigecycline Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Tigecycline Industry

1.7 COVID-19 Impact: Tigecycline Market Trends

2 Global Tigecycline Quarterly Market Size Analysis

2.1 Tigecycline Business Impact Assessment - COVID-19

2.1.1 Global Tigecycline Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Tigecycline Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Tigecycline Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Tigecycline Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Tigecycline Factory Price by Manufacturers

3.3 Location of Key Manufacturers Tigecycline Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Tigecycline Market

3.5 Key Manufacturers Tigecycline Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Tigecycline Segments, By Type

4.1 Introduction

1.4.1 Gram Positive Bacteria

1.4.2 Gram Negative Bacteria

4.2 By Type, Global Tigecycline Market Size, 2019-2021

4.2.1 By Type, Global Tigecycline Market Size by Type, 2020-2021

4.2.2 By Type, Global Tigecycline Price, 2020-2021

5 Impact of Covid-19 on Tigecycline Segments, By Application

5.1 Overview

5.5.1 Skin & Soft Tissue Infections

5.5.2 Complicated Intra-abdominal Infections

5.5.3 Community-acquired Bacterial Pneumonia

5.2 By Application, Global Tigecycline Market Size, 2019-2021

5.2.1 By Application, Global Tigecycline Market Size by Application, 2019-2021

5.2.2 By Application, Global Tigecycline Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Business Overview

7.1.2 Pfizer Tigecycline Quarterly Production and Revenue, 2020

7.1.3 Pfizer Tigecycline Product Introduction

7.1.4 Pfizer Response to COVID-19 and Related Developments

7.2 Hisun Pharma

7.2.1 Hisun Pharma Business Overview

7.2.2 Hisun Pharma Tigecycline Quarterly Production and Revenue, 2020

7.2.3 Hisun Pharma Tigecycline Product Introduction

7.2.4 Hisun Pharma Response to COVID-19 and Related Developments

7.3 Hansoh Pharma

7.3.1 Hansoh Pharma Business Overview

7.3.2 Hansoh Pharma Tigecycline Quarterly Production and Revenue, 2020

7.3.3 Hansoh Pharma Tigecycline Product Introduction

7.3.4 Hansoh Pharma Response to COVID-19 and Related Developments

7.4 Jiagsu Aosaikang Pharmaceutical

7.4.1 Jiagsu Aosaikang Pharmaceutical Business Overview

7.4.2 Jiagsu Aosaikang Pharmaceutical Tigecycline Quarterly Production and Revenue, 2020

7.4.3 Jiagsu Aosaikang Pharmaceutical Tigecycline Product Introduction

7.4.4 Jiagsu Aosaikang Pharmaceutical Response to COVID-19 and Related Developments

7.5 HICIN Pharma

7.5.1 HICIN Pharma Business Overview

7.5.2 HICIN Pharma Tigecycline Quarterly Production and Revenue, 2020

7.5.3 HICIN Pharma Tigecycline Product Introduction

7.5.4 HICIN Pharma Response to COVID-19 and Related Developments

7.6 Abbott Laboratories

7.6.1 Abbott Laboratories Business Overview

7.6.2 Abbott Laboratories Tigecycline Quarterly Production and Revenue, 2020

7.6.3 Abbott Laboratories Tigecycline Product Introduction

7.6.4 Abbott Laboratories Response to COVID-19 and Related Developments

7.7 Amgen

7.7.1 Amgen Business Overview

7.7.2 Amgen Tigecycline Quarterly Production and Revenue, 2020

7.7.3 Amgen Tigecycline Product Introduction

7.7.4 Amgen Response to COVID-19 and Related Developments

7.8 Astrazeneca

7.8.1 Astrazeneca Business Overview

7.8.2 Astrazeneca Tigecycline Quarterly Production and Revenue, 2020

7.8.3 Astrazeneca Tigecycline Product Introduction

7.8.4 Astrazeneca Response to COVID-19 and Related Developments

7.9 Merck

7.9.1 Merck Business Overview

7.9.2 Merck Tigecycline Quarterly Production and Revenue, 2020

7.9.3 Merck Tigecycline Product Introduction

7.9.4 Merck Response to COVID-19 and Related Developments

7.10 Novartis

7.10.1 Novartis Business Overview

7.10.2 Novartis Tigecycline Quarterly Production and Revenue, 2020

7.10.3 Novartis Tigecycline Product Introduction

7.10.4 Novartis Response to COVID-19 and Related Developments

7.11 Roche Holdings

7.11.1 Roche Holdings Business Overview

7.11.2 Roche Holdings Tigecycline Quarterly Production and Revenue, 2020

7.11.3 Roche Holdings Tigecycline Product Introduction

7.11.4 Roche Holdings Response to COVID-19 and Related Developments

7.12 Johnson & Johnson

7.12.1 Johnson & Johnson Business Overview

7.12.2 Johnson & Johnson Tigecycline Quarterly Production and Revenue, 2020

7.12.3 Johnson & Johnson Tigecycline Product Introduction

7.12.4 Johnson & Johnson Response to COVID-19 and Related Developments

7.13 Sanofi

7.13.1 Sanofi Business Overview

7.13.2 Sanofi Tigecycline Quarterly Production and Revenue, 2020

7.13.3 Sanofi Tigecycline Product Introduction

7.13.4 Sanofi Response to COVID-19 and Related Developments

7.14 Lifecare Innovations

7.14.1 Lifecare Innovations Business Overview

7.14.2 Lifecare Innovations Tigecycline Quarterly Production and Revenue, 2020

7.14.3 Lifecare Innovations Tigecycline Product Introduction

7.14.4 Lifecare Innovations Response to COVID-19 and Related Developments

7.15 Progen Nutraceuticals

7.15.1 Progen Nutraceuticals Business Overview

7.15.2 Progen Nutraceuticals Tigecycline Quarterly Production and Revenue, 2020

7.15.3 Progen Nutraceuticals Tigecycline Product Introduction

7.15.4 Progen Nutraceuticals Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Tigecycline Supply Chain Analysis

8.1.1 Tigecycline Supply Chain Analysis

8.1.2 Covid-19 Impact on Tigecycline Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Tigecycline Distribution Channels

8.2.2 Covid-19 Impact on Tigecycline Distribution Channels

8.2.3 Tigecycline Distributors

8.3 Tigecycline Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Tigecycline Assessment

Table 9. COVID-19 Impact: Tigecycline Market Trends

Table 10. COVID-19 Impact Global Tigecycline Market Size

Table 11. Global Tigecycline Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)

Table 12. Global Tigecycline Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

Table 13. Global Tigecycline Quarterly Market Size, 2020 (US$ Million) & (K MT)

Table 14. Global Tigecycline Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Tigecycline Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)

Table 16. Global Tigecycline Market Growth Drivers

Table 17. Global Tigecycline Market Restraints

Table 18. Global Tigecycline Market Opportunities

Table 19. Global Tigecycline Market Challenges

Table 20. Key Manufacturers Tigecycline Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Tigecycline Market Size, 2019 (K MT) & (US$ Million)

Table 22. Tigecycline Factory Price by Manufacturers 2020 (USD/MT)

Table 23. Location of Key Manufacturers Tigecycline Manufacturing Plants

Table 24. Key Manufacturers Tigecycline Market Served

Table 25. Date of Key Manufacturers Enter into Tigecycline Market

Table 26. Key Manufacturers Tigecycline Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Tigecycline Market Size by Type, 2020, (US$ Million)

Table 29. Global Tigecycline Market Size by Type, 2020 (K MT)

Table 30. Global Tigecycline Price: by Type, 2020-2021 (USD/MT)

Table 31. Global Tigecycline Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Tigecycline Market Size by Application, 2020-2021 (K MT)

Table 33. Global Tigecycline Price: by Application, 2020-2021 (USD/MT)

Table 34. Global Tigecycline Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Tigecycline Market Size by Region, 2019-2021 (K MT)

Table 36. By Country, North America Tigecycline Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Tigecycline Market Size, 2019-2021 (K MT)

Table 38. US Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 39. Canada Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Tigecycline Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Tigecycline Market Size, 2019-2021 (K MT)

Table 43. Germany Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 44. France Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 45. UK Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 46. Italy Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Tigecycline Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Tigecycline Market Size, 2019-2021 (K MT)

Table 50. China Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 51. Japan Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 52. South Korea Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 53. India Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 54. ASEAN Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 55. Latin America Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 56. Middle East and Africa Tigecycline Market Size, 2019-2021 (US$ Million) & (K MT)

Table 57. Pfizer Business Overview

Table 58. Pfizer Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Pfizer Tigecycline Product

Table 60. Pfizer Response to COVID-19 and Related Developments

Table 61. Hisun Pharma Business Overview

Table 62. Hisun Pharma Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Hisun Pharma Tigecycline Product

Table 64. Hisun Pharma Response to COVID-19 and Related Developments

Table 65. Hansoh Pharma Business Overview

Table 66. Hansoh Pharma Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Hansoh Pharma Tigecycline Product

Table 68. Hansoh Pharma Response to COVID-19 and Related Developments

Table 69. Jiagsu Aosaikang Pharmaceutical Business Overview

Table 70. Jiagsu Aosaikang Pharmaceutical Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Jiagsu Aosaikang Pharmaceutical Tigecycline Product

Table 72. Jiagsu Aosaikang Pharmaceutical Response to COVID-19 and Related Developments

Table 73. HICIN Pharma Business Overview

Table 74. HICIN Pharma Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. HICIN Pharma Tigecycline Product

Table 76. HICIN Pharma Response to COVID-19 and Related Developments

Table 77. Abbott Laboratories Business Overview

Table 78. Abbott Laboratories Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Abbott Laboratories Tigecycline Product

Table 80. Abbott Laboratories Response to COVID-19 and Related Developments

Table 81. Amgen Business Overview

Table 82. Amgen Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Amgen Tigecycline Product

Table 84. Amgen Response to COVID-19 and Related Developments

Table 85. Astrazeneca Business Overview

Table 86. Astrazeneca Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Astrazeneca Tigecycline Product

Table 88. Astrazeneca Response to COVID-19 and Related Developments

Table 89. Merck Business Overview

Table 90. Merck Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Merck Tigecycline Product

Table 92. Merck Response to COVID-19 and Related Developments

Table 93. Novartis Business Overview

Table 94. Novartis Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Novartis Tigecycline Product

Table 96. Novartis Response to COVID-19 and Related Developments

Table 97. Roche Holdings Business Overview

Table 98. Roche Holdings Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Roche Holdings Tigecycline Product

Table 100. Roche Holdings Response to COVID-19 and Related Developments

Table 101. Johnson & Johnson Business Overview

Table 102. Johnson & Johnson Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Johnson & Johnson Tigecycline Product

Table 104. Johnson & Johnson Response to COVID-19 and Related Developments

Table 105. Sanofi Business Overview

Table 106. Sanofi Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Sanofi Tigecycline Product

Table 108. Sanofi Response to COVID-19 and Related Developments

Table 109. Lifecare Innovations Business Overview

Table 110. Lifecare Innovations Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. Lifecare Innovations Tigecycline Product

Table 112. Lifecare Innovations Response to COVID-19 and Related Developments

Table 113. Progen Nutraceuticals Business Overview

Table 114. Progen Nutraceuticals Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 115. Progen Nutraceuticals Tigecycline Product

Table 116. Progen Nutraceuticals Response to COVID-19 and Related Developments

Table 117. Tigecycline Distributors List

Table 118. Tigecycline Customers List

Table 119. Covid-19 Impact on Tigecycline Customers

List of Figures

Figure 1. Tigecycline Product Picture

Figure 2. Tigecycline Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Tigecycline Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Tigecycline Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Tigecycline Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Tigecycline Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Tigecycline Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Tigecycline Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Tigecycline Market Size Market Share, 2019-2021